$ZYME Income Statement | Understand Stock

$ZYME

$28.37 +$0.15 (0.53%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Revenue:
Research and development collaborations (note 11)
Operating expenses:
Research and development
General and administrative
Impairment on IPR&D (note 6)
Total operating expenses
Loss from operations
Other income:
Interest income
Other (expense) income, net (note 12)
Total other income, net
Loss before income taxes
Income tax (expense) recovery (note 13)
Net loss
Other comprehensive income (loss):
Unrealized income (loss) on available for sale securities, net of tax of nil (note 5)
Total other comprehensive income (loss)
Comprehensive loss
Net loss per common share (note 4):
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average common stock outstanding (note 4):
Basic (in shares)
Diluted (in shares)

Comments